// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























229 Abstracts

Metformin and lactic acidosis: a potentially lethal relationship during intercurrent illness

Enalda Demaj - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Metfomin induced lactic acidosis

Biaxin

Level of knowledge about work accidents and competencies among nursing students

Vjollca Shpata - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Actualities in the Diagnosis and Treatment of Thyroid Cancer in Albania

Dashamir Xhemal Gjergji - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Thyroid nodules

N/A

Major Depressive Disorder in View of Bipolar Spectrum

A. Hashorva - European Congress of Psychiatry (EPA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Brain Drain or Gain? Psychiatric Trainees On the Move

M. Pinto da Costa - European Congress of Psychiatry (EPA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

THE CLINICAL AND IMAGERY FINDINGS IN PATIENTS WITH POST STROKE DEMENTIA

D. Naco - International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PDTM) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

PARKINSONISM-DEMENTIA

Danjela Ndoja - International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PDTM) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Parkinson's disease

N/A

EARLY ONSET PARKINSONISM

D. Ndoja - International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PDTM) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

Levodopa

Ultrasonographic Is More Sensitive Than Traditional Clinical Evaluation in the Detection of Hands and Wrists Synovitis and Digital Soft Tissue Involvement in Early Psoriatic Arthritis

Francesca B - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Psoriatic arthritis

Orphenadrine Citrate

Evaluation of Alternative Samples for Sterility Testing of HPC-CB Products

Maria S Albano - European Group for Blood and Marrow Transplantation (EBMT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Infertility

N/A

PANCREATIC CANCER AND LIFESTYLE CHARACTERISTICS: A POPULATION-BASED STUDY IN ALBANIA

Fatjona Kraja - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic cancer

N/A

THE EFFECT OF 1 YEAR ORAL IBANDRONATE ON BONE MINERAL DENSITY AND HR QOL AN OUTPATIENT STUDY IN A SPECIALITY CLINIC IN ALBANIA

B. Hebibasi - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

Ibandronic acid

The Effect of 1 Year Oral Ibandronate on Bone Mineral Density and HR QoL An Outpatient Study in A Speciality Clinic in Albania

B. Hebibasi - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

Ibandronic acid

Fractalkine/CX3CR1 Signaling Promotes Angiogenic Potentials in CX3CR1 Expressing Monocytes

Jeong A Kim - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Single-Agent Ibrutinib in Recurrent/Refractory Central Nervous System Lymphoma

Christian Grommes - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

CNS lymphoma

Ibrutinib

A PROPOSAL OF DEFINITION OF EARLY SYMPTOMATIC KNEE OSTEOARTHRITIS (ESKOA). RESULTS FROM AN INTERNATIONAL CONSENSUS PROMOTED BY THE ITALIAN SOCIETY OF RHEUMATOLOGY (SIR)

A. Migliore - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

PULMONARY INVOLVEMENT IN PATIENT DIAGNOSED WITH MORPHEA

T. Backa Cico - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Scleroderma

N/A

IL-S ROLE IN HYPERTROFIC LEFT VENTRICUL IN PATIENT WITH RHEUMATOID ARTHRITIS

E. Rapushi - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Left ventricular hypertrophy

ILS-969

DACTYLITIS ULTRASONOGRAPHIC FEATURES CORRELATION TO DERMATOLOGICAL, GENETIC AND ACTIVITY INDICES IN EARLY PSORIATIC ARTHRITIS PATIENTS

F. Bandinelli - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Psoriatic arthritis

Orphenadrine Citrate

THE INCIDENCE OF RHEUMATOID ARTHRITIS IN TIRANA, ALBANIA

V. Duraj - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Copyright © 2026. QuantiNova All rights reserved